Ultrasound Elastography Correlates Treatment Response by Antiviral Therapy in Patients with Chronic Hepatitis C

被引:17
|
作者
Yada, Norihisa [1 ]
Sakurai, Toshiharu [1 ]
Minami, Tomohiro [1 ]
Arizumi, Tadaaki [1 ]
Takita, Masahiro [1 ]
Inoue, Tatsuo [1 ]
Hagiwara, Satoru [1 ]
Ueshima, Kazuomi [1 ]
Nishida, Naoshi [1 ]
Kudo, Masatoshi [1 ]
机构
[1] Kinki Univ, Sch Med, Dept Gastroenterol & Hepatol, Osaka 5898511, Japan
关键词
Antiviral therapy; Liver stiffness; Liver fibrosis; Liver fibrosis index; Strain elastography; TRANSIENT ELASTOGRAPHY; LIVER STIFFNESS; HEPATOCELLULAR-CARCINOMA; INTERFERON THERAPY; EFSUMB GUIDELINES; VIRAL-HEPATITIS; RISK-ASSESSMENT; CLINICAL-USE; FIBROSIS; RECOMMENDATIONS;
D O I
10.1159/000368155
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To investigate the relationship between tissue elasticity before and after antiviral therapy and shear wave as well as strain elastography. Methods: FibroScan and real-time tissue elastography were performed before and after antiviral therapy for chronic hepatitis C, and treatment efficacy and elastographic findings were comparatively analyzed. Elasticity was evaluated by measuring liver stiffness (LS) in kilopascals using FibroScan, and the liver fibrosis index (LFI) was assessed by real-time tissue elastography. Results: LS and LFI correlated well before and after therapy (r = 0.567, p = 0.003 and r = 0.576, p = 0.002, respectively). In the group without a sustained virological response (SVR), LS increased in 4 of 5 patients. Patients with an increase in both LS and LFI were all in the non-SVR group (3/3, 100%). In addition, LS increased in all patients except 1 in the non-SVR group (4/5, 80%). In the SVR group, both LS and LFI decreased in all patients except 1 (18/19, 94.7%). In the patient with an increase in LS despite achieving SVR, LS decreased quickly after alcohol cessation. Conclusions: With a few exceptions, SVR improved LS. All patients with an increase in LFI were in the non-SVR group, even though LFI decreased in 2 patients. Our findings suggest that an LFI increase indicates lack of treatment efficacy with antiviral therapy. LFI may be useful for the assessment of treatment efficacy in patients with worsening of LS despite achieving SVR with antiviral therapy. (C) 2014 S. Karger AG, Basel
引用
收藏
页码:118 / 123
页数:6
相关论文
共 50 条
  • [1] Antiviral therapy for patients with chronic hepatitis C
    Heathcote, J
    SEMINARS IN LIVER DISEASE, 2000, 20 (02) : 185 - 199
  • [2] Definition of response to antiviral therapy in chronic hepatitis C
    Craxï, A
    Cammà, C
    Giunta, M
    JOURNAL OF HEPATOLOGY, 1999, 31 : 160 - 167
  • [3] The Lebervenendruckgradient as a predictor for the response to antiviral therapy in patients with chronic hepatitis C and cirrhosis
    Reiberger, Thomas
    Rutter, Karoline
    Ferlitsch, Arnulf
    Hofer, Sandra
    Beinhardt, Sandra
    Ferenci, Peter
    Peck-Radosavljevic, Markus
    WIENER KLINISCHE WOCHENSCHRIFT, 2009, 121 (15-16) : A24 - A25
  • [4] Ethnic response to combination antiviral therapy in chronic hepatitis C patients.
    Akoma-Sey, V
    Utoh, JF
    Clark, D
    Clark, C
    Singh, S
    HEPATOLOGY, 2000, 32 (04) : 351A - 351A
  • [5] Serum ferritin levels in chronic hepatitis C patients during antiviral therapy and prediction of treatment response
    Barut, Sener
    Gunal, Ozgur
    Erkorkmaz, Unal
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2012, 44 (10) : 761 - 765
  • [6] Treatment Options for Patients With Chronic Hepatitis C Not Responding to Initial Antiviral Therapy
    Jacobson, Ira M.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2009, 7 (09) : 921 - 930
  • [7] Use of antiviral therapy in patients with chronic hepatitis C
    Dragomiretskaya, Natalia
    Izha, Anna
    Kalinichenko, Nikolay
    Szark-Eckardt, Miroslawa
    Klimczyk, Mariusz
    Cieslicka, Miroslawa
    Muszkieta, Radoslaw
    Prusik, Krzysztof
    Napierala, Marek
    Zukowska, Hanna
    Zukow, Walery
    OPEN MEDICINE, 2015, 10 (01): : 209 - 215
  • [8] Quasispecies as predictive response factors for antiviral treatment in patients with chronic hepatitis C
    Salmeron, Javier
    De Rueda, Paloma Munoz
    Ruiz-Extremera, Angela
    Casado, Jorge
    Huertas, Carlos
    Bernal, Maria Del Carmen
    Rodriguez, Luis
    Palacios, Angel
    DIGESTIVE DISEASES AND SCIENCES, 2006, 51 (05) : 960 - 967
  • [9] Quasispecies as Predictive Response Factors for Antiviral Treatment in Patients with Chronic Hepatitis C
    Javier Salmerón
    Paloma Muñoz De Rueda
    Ángela Ruiz-Extremera
    Jorge Casado
    Carlos Huertas
    Maria Del Carmen Bernal
    Luis Rodríguez
    Ángel Palacios
    Digestive Diseases and Sciences, 2006, 51
  • [10] Racial differences in the response to antiviral therapy for chronic hepatitis C
    Colantoni, A
    De Maria, N
    Idilman, R
    Harig, J
    Van Thiel, DH
    JOURNAL OF HEPATOLOGY, 2000, 32 : 194 - 194